is increasingly moving into the health care arena and helping to streamline medical processes — including the creation of new drugs.
Paxlovid, which is currently the only medication available to treat COVID symptoms, has been linked to some undesirable side effects, Insilico noted. Dr. Alex Zhavoronkov, left, is pictured with Dr. Michael Levitt, Nobel Prize winner in chemistry, who has spoken previously about the development of Insilico's novel inhibitor for COVID.
"The drug has been shown to be effective against all variants, as well as other types of coronaviruses that cause diseases, including severe acute respiratory syndrome and Middle East respiratory syndrome ," Zhavoronkov told Fox News Digital.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: